New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Assessment of Donor quality and risk of graft failure after liver transplantation: The ID2 EAL score.
Assessment of Donor quality and risk of graft failure after liver transplantation: The ID2 EAL score. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons Asrani, S. K., Saracino, G., Wall, A., Trotter, J. F., Testa, G., Hernaez, R., Sharma, P., Kwong, A., Banerjee, S., McKenna, G. 2022Abstract
Accurate assessment of donor quality at the time of organ offer for liver transplantation candidates may be inadequately captured by the donor risk index (DRI). We sought to develop and validate a novel objective and simple model to assess donor risk using donor level variables available at the time of organ offer. We utilized national data from candidates undergoing primary LT (2013-2019) and assessed prediction of graft failure 1 year after LT. ID2 EAL score: The final components were donor Insulin dependent diabetes mellitus, Donor type (DCD or DBD), cause of Death=CVA, serum creatinine, Age, height and weight (length). The ID2 EAL score had better discrimination than DRI using bootstrap corrected concordant index over time, especially in the current era. We explored donor-recipient matching. Relative risk of graft failure ranged from 1.15-3.5 based on relevant donor-recipient matching by the ID2 EAL score. As an example, for certain recipients, a young DCD donor offer was preferable to an older DBD with relevant comorbidities. The ID2 EAL score may serve as an important tool for patient discussion about donor risk and decisions regarding offer acceptance. In addition, the score may be preferable to succinctly capture donor risk in future organ allocation that considers continuous distribution.
View details for DOI 10.1111/ajt.17191
View details for PubMedID 36053559